Loading...

Meridian Bioscience, Inc.

VIVO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$33.97
$0.00(0.00%)

Meridian Bioscience, Inc. (VIVO) Stock Overview

Explore Meridian Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.9/100

Key Financials

Market Cap1.5B
P/E Ratio35.21
EPS (TTM)$1.61
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$60.77

VIVO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Meridian Bioscience, Inc. (VIVO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $60.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.21 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
6.19%
6-Month Change
3.41%
Year-to-Date (YTD) Change
1.55%
1-Year Change
34.48%
3-Year Change
308.78%
5-Year Change
146.16%
All-Time (Max) Change
1839.88%

Contact Information

https://www.meridianbioscience.com
513 271 3700
3471 River Hills Drive, Cincinnati, OH, 45244

Company Facts

690 Employees
IPO DateJul 29, 1986
CountryUS

Frequently Asked Questions

;